According to #TechSci Research report, the Global PCOS Treatment Market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period. Report URL - https://bit.ly/3boCto2 Visit our website @ https://www.techsciresearch.com/ For more market research news visit our blog: https://techsciblog.com/

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
GLOBAL PCOS TREATMENT MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

2. 2
Scope of Report
Product of Interest (POI): PCOS Treatment
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
Polycystic ovary syndrome (PCOS) is a condition that affects a woman's hormone levels. Women with
PCOS produce higher-than-normal amounts of male hormones. This hormone imbalance causes them to
skip menstrual periods and makes it harder for them to get pregnant.
Market Segmentation
DRUG
• Ovulation Inducing Agents
• Insulin-Sensitizing Agents
• Oral Contraceptives
• Antiandrogens
• Anti-Depressants
• Insulin-Sensitizing Agents
• Anti-Obesity Drugs
• Others
SURGERY
• Ovarian Wedge Resection
• Cyst Aspiration
• Laparoscopic Ovarian Drilling
DIAGNOSIS
• Pelvic Examination
• Ultrasound
• Blood Tests
END USER
• Hospitals & Clinics
• Ambulatory Surgical
Centers
• Fertility Clinics
REGION
• Asia Pacific
• Europe
• North America
• South America
• Middle East & Africa

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global PCOS Treatment Market
4. Executive Summary
5. Voice of Customer
6. Global PCOS Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian
Drilling)
6.2.2.
By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral
Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents,
Anti-Obesity Drugs, Others)
6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
6.2.5. By Company (2019)
6.2.6. By Region
6.3. Product Market Map
7. Asia-Pacific PCOS Treatment Market Outlook

4. 4
Table of Contents
S. No. Contents Page No.
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Surgery
7.2.2. By Drug
7.2.3. By Diagnosis
7.2.4. By End User
7.2.5. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China PCOS Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Surgery
7.3.1.2.2. By Drug
7.3.1.2.3. By Diagnosis
7.3.1.2.4. By End User
7.3.2. India PCOS Treatment Market Outlook
7.3.2.1. Market Size & Forecast

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Surgery
7.3.2.2.2. By Drug
7.3.2.2.3. By Diagnosis
7.3.2.2.4. By End User
7.3.3. Australia PCOS Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Surgery
7.3.3.2.2. By Drug
7.3.3.2.3. By Diagnosis
7.3.3.2.4. By End User
7.3.4. Japan PCOS Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast

6. 6
Table of Contents
S. No. Contents Page No.
7.3.4.2.1. By Surgery
7.3.4.2.2. By Drug
7.3.4.2.3. By Diagnosis
7.3.4.2.4. By End User
7.3.5. South Korea PCOS Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Surgery
7.3.5.2.2. By Drug
7.3.5.2.3. By Diagnosis
7.3.5.2.4. By End User
8. Europe PCOS Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Surgery
8.2.2. By Drug

7. 7
Table of Contents
S. No. Contents Page No.
8.2.3. By Diagnosis
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France PCOS Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Surgery
8.3.1.2.2. By Drug
8.3.1.2.3. By Diagnosis
8.3.1.2.4. By End User
8.3.2. Germany PCOS Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Surgery
8.3.2.2.2. By Drug

8. 8
Table of Contents
S. No. Contents Page No.
8.3.2.2.3. By Diagnosis
8.3.2.2.4. By End User
8.3.3. United Kingdom PCOS Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Surgery
8.3.3.2.2. By Drug
8.3.3.2.3. By Diagnosis
8.3.3.2.4. By End User
8.3.4. Italy PCOS Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Surgery
8.3.4.2.2. By Drug
8.3.4.2.3. By Diagnosis
8.3.4.2.4. By End User

9. 9
Table of Contents
S. No. Contents Page No.
8.3.5. Spain PCOS Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Surgery
8.3.5.2.2. By Drug
8.3.5.2.3. By Diagnosis
8.3.5.2.4. By End User
9. North America PCOS Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Surgery
9.2.2. By Drug
9.2.3. By Diagnosis
9.2.4. By End User
9.2.5. By Country
9.3. North America: Country Analysis

10. 10
Table of Contents
S. No. Contents Page No.
9.3.1. United States PCOS Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Surgery
9.3.1.2.2. By Drug
9.3.1.2.3. By Diagnosis
9.3.1.2.4. By End User
9.3.2. Mexico PCOS Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Surgery
9.3.2.2.2. By Drug
9.3.2.2.3. By Diagnosis
9.3.2.2.4. By End User
9.3.3. Canada PCOS Treatment Market Outlook
9.3.3.1. Market Size & Forecast

11. 11
Table of Contents
S. No. Contents Page No.
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Surgery
9.3.3.2.2. By Drug
9.3.3.2.3. By Diagnosis
9.3.3.2.4. By End User
10. South America PCOS Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Surgery
10.2.2. By Drug
10.2.3. By Diagnosis
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil PCOS Treatment Market Outlook
10.3.1.1. Market Size & Forecast

12. 12
Table of Contents
S. No. Contents Page No.
10.3.1.1.1 By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Surgery
10.3.1.2.2. By Drug
10.3.1.2.3. By Diagnosis
10.3.1.2.4. By End User
10.3.2. Argentina PCOS Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Surgery
10.3.2.2.2. By Drug
10.3.2.2.3. By Diagnosis
10.3.2.2.4. By End User
10.3.3. Colombia PCOS Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share & Forecast

13. 13
Table of Contents
S. No. Contents Page No.
10.3.3.2.1. By Surgery
10.3.2.2.2. By Drug
10.3.2.2.3. By Diagnosis
10.3.2.2.4. By End User
11. Middle East and Africa PCOS Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Surgery
11.2.2. By Drug
11.2.3. By Diagnosis
11.2.4. By End User
11.2.5. By Country
11.3. Middle East & Africa : Country Analysis
11.3.1. South Africa PCOS Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast

14. 14
Table of Contents
S. No. Contents Page No.
11.3.1.2.1. By Surgery
11.3.1.2.2. By Drug
11.3.1.2.3. By Diagnosis
11.3.1.2.4. By End User
11.3.2. Saudi Arabia PCOS Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Surgery
11.3.2.2.2. By Drug
11.3.2.2.3. By Diagnosis
11.3.2.2.4. By End User
11.3.3. UAE PCOS Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Surgery
11.3.3.2.2. By Drug

15. 15
Table of Contents
S. No. Contents Page No.
11.3.3.2.3. By Diagnosis
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Commonly Used PCOS Drugs to control different symptoms
15. Competitive Landscape
15.1. Bristol-Myers Squibb Company
15.2. Bayer AG
15.3. Pfizer, Inc.
15.4. Abbott Laboratories, Inc.
15.5. Merck & Co., Inc.
15.6. Sanofi SA
15.7. AstraZeneca Plc
15.8. Novartis AG
15.9. Teva Pharmaceutical Industries Limited
15.10. Ferring Pharmaceuticals, Inc.

16. 16
Table of Contents
S. No. Contents Page No.
16. Strategic Recommendations
17. About Us & Disclaimer

17. RESEARCHMETHODOLOGY

18. 18
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global PCOS treatment
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global PCOS treatment
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

19. 19
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global PCOS treatment market. The team has
this market, while considering the major influencing factors such as increase in number of PCOS treatment and growth in healthcare
forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global
Methodology Followed for Calculation of Market Size:
• Market Size by Value & Volume: Market size, in terms of value & volume, for the year 2019 was calculated based on information
collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as
influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 PCOS treatment companies, 100 – 120 end users, and 15 – 20 industry experts and other
treatment market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard
averaged out, to arrive at the market size data during 2015-2019.

20. 20
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by surgery, by drug, by diagnosis, by end user and by region. Removing the outlier
responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares.
Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares by surgery, by drug, by Diagnosis, by end user and by region were calculated based on the responses received through primary surveys with industry experts, in
which the respondents were asked about the market shares or revenue generated from various segments of PCOS treatment market. The final shares were calculated by taking the
geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global PCOS treatment market, TechSci Research
used various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

21. 21
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
 Bristol-Myers Squibb Company
 Bayer AG
 Pfizer, Inc.
 Abbott Laboratories, Inc.
 Merck & Co., Inc.
 Sanofi SA
 AstraZeneca Plc
 Novartis AG
 Teva Pharmaceutical Industries Limited
 Ferring Pharmaceuticals, Inc.
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

22. 22
Industry Brief
According to TechSci Research report, “Global PCOS Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis (Pelvic
Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast &
Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable rate during the forecast period on account of the
rising awareness pertaining to diseases and reproductive health among the population. Additionally, initiatives taken by various government and
non-government organizations for spreading awareness and providing schemes and services for the welfare of women is further expected to
positively impact the growth of market over the next few years. Furthermore, easy access to PCOS therapeutics, growing demand for PCOS
medication and rising popularity of combination therapy are further expected to foster the growth of market through 2025. However, easy
availability of generics and off the label drugs might hinder the growth of market during forecast period. Additionally, lack of approved
therapeutics and side effects of the available drugs might hamper the growth of market over the next few years. Also, at present no targeted
therapy is available for this syndrome & it is only controlled through medication and some surgical procedures.
The global PCOS treatment market is segmented based on treatment, diagnosis, end user, company and region. Based on treatment the market
can be bifurcated into surgeries and drug treatment. The drug treatment segment can further be categorized into oral contraceptives,
antiandrogens, anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The insulin-sensitizing agents segment is expected to
dominate the market since they lower the insulin levels in blood and help in maintaining hormonal balance. The surgeries segment is further
bifurcated into ovarian wedge resection and laparoscopic ovarian drilling. The ovarian wedge resection segment is expected to witness
significant growth during the forecast years as this method removes some part of the ovary, which helps in regulating menstrual cycle and
promotes ovulation.
Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva
Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan N.V., Millendo
Therapeutics, Inc. and others are some of the leading players operating in global PCOS treatment market. The companies operating in the
market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in January 2106,
AstraZeneca announced that they have started start up for women health treatment and invested USD62 million in drug development for poly
cystic ovarian disorder.
“North America is expected to dominate the global PCOS treatment market during the forecast period, owing to the presence of well-developed
healthcare infrastructure in the region. Additionally, availability of skilled medical personnel coupled with large PCOS patient pool in the region is
further expected to create lucrative opportunities for the market players over the next few years. Furthermore, better reimbursement policies in
the region are encouraging the population for PCOS treatment and surgeries, thereby anticipated to drive the growth of market over the next few
years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

23. 23
Sample Data - Snapshot
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
Global PCOS Treatment Market Size, By Value (USD Million), 2015–2025F
CAGR By Value
XX%
CAGR By Value
YY%
North America PCOS Treatment Market Share, By Surgery, By Value, 2015–2025F
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
40%
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Ovarian Wedge Resection Cyst Aspiration Laparoscopic Ovarian Drilling
United State PCOS Treatment Market Share, By Drug, By Value, 2015–2025F
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Ovulation Inducing Agents Insulin-Sensitizing Agents Oral Contraceptives Antiandrogens
Anti-Depressants Anti-Obesity Drugs Others

24. 24
Report Ordering
Report Name: GLOBAL PCOS TREATMENT MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
To View Sample OR Purchase Report
License Type Price
Single User License $4450
Multi-User License $5450
Custom Research License $9450

25. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality
analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global
company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Spinal Cord Stimulation Devices Market By Product Type (Rechargeable v/s Non-Rechargeable) By Application (Failed Back Syndrome,
Complex Regional Pain Syndrome, Degenerative Disk Disease, Unsuccessful Disk Surgery, Others) By End User (Hospitals & Clinics,
Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026.
• ◾Global Topical Drug Delivery Market By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug
Delivery) By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others) By Distribution Channel (Online vs. Offline) By
Region, Competition Forecast & Opportunities, 2026
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com